Cargando…

Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial

BACKGROUND: Liquid biopsy based on cell-free DNA circulating in plasma has shown solid results as a non-invasive biomarker. In the present study we evaluated the utility of circulating free DNA (cfDNA) and the sub-type tumor DNA (ctDNA) in hepatocellular cancer (HCC) patients to assess therapy respo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alunni-Fabbroni, Marianna, Rönsch, Kerstin, Huber, Thomas, Cyran, Clemens C., Seidensticker, Max, Mayerle, Julia, Pech, Maciej, Basu, Bristi, Verslype, Chris, Benckert, Julia, Malfertheiner, Peter, Ricke, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771167/ https://www.ncbi.nlm.nih.gov/pubmed/31570105 http://dx.doi.org/10.1186/s12967-019-2079-9

Ejemplares similares

Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial
por: Shuen, Timothy Wai Ho, et al.
Publicado: (2022)

Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial
por: Öcal, Osman, et al.
Publicado: (2021)

Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial
por: Surov, Alexey, et al.
Publicado: (2023)

NMR-Based Lipid Metabolite Profiles to Predict Outcomes in Patients Undergoing Interventional Therapy for a Hepatocellular Carcinoma (HCC): A Substudy of the SORAMIC Trial
por: Geyer, Thomas, et al.
Publicado: (2021)

Circulating Cell-Free DNA Combined to Magnetic Resonance Imaging for Early Detection of HCC in Patients with Liver Cirrhosis
por: Alunni-Fabbroni, Marianna, et al.
Publicado: (2021)

Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial
por: Seidensticker, Max, et al.
Publicado: (2023)

Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial
por: Öcal, Osman, et al.
Publicado: (2021)

Correlation of liver enhancement in gadoxetic acid–enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial
por: Öcal, Osman, et al.
Publicado: (2021)

Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial
por: Geyer, Thomas, et al.
Publicado: (2022)

Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression
por: Öcal, Osman, et al.
Publicado: (2022)

Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization
por: Öcal, Osman, et al.
Publicado: (2021)

Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only—A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort
por: Seidensticker, Max, et al.
Publicado: (2022)

Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma
por: Leineweber, Can G., et al.
Publicado: (2023)

Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
por: Öcal, Osman, et al.
Publicado: (2022)

Reproducibility of CT-Based Hepatocellular Carcinoma Radiomic Features across Different Contrast Imaging Phases: A Proof of Concept on SORAMIC Trial Data
por: Ibrahim, Abdalla, et al.
Publicado: (2021)

Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival
por: Seidensticker, Ricarda, et al.
Publicado: (2018)

The Impact of Unilateral (90)Y-radioembolization on Functional Changes in the Contralateral Hepatic Lobe: The Prospective, Open-label RadioEmbolization, Volumetry, and Liver FuncTion Measurements (REVoluTion) Study
por: Garlipp, Benjamin, et al.
Publicado: (2021)

Prognostic role of radiomics‐based body composition analysis for the 1‐year survival for hepatocellular carcinoma patients
por: Saalfeld, Sylvia, et al.
Publicado: (2023)

Extensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic Cholangiocarcinoma
por: Seidensticker, Ricarda, et al.
Publicado: (2016)

Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes
por: Seidensticker, Max, et al.
Publicado: (2011)

Prevention of radiation-induced liver toxicity after interstitial HDR brachytherapy by pentoxifylline and ursodeoxycholic acid: patient compliance and outcome in a randomized trial
por: Damm, Robert, et al.
Publicado: (2023)

The role of the gastric bacterial microbiome in gastric cancer: Helicobacter pylori and beyond
por: Schulz, Christian, et al.
Publicado: (2019)

Improvement of Contrast Media Enhancement in CTA Evaluating Pulmonary Embolism by Utilizing ‘Delayed’ Bolus Tracking in the Descending Aorta
por: Damm, Robert, et al.
Publicado: (2016)

Treatment of hepatic pancreatic ductal adenocarcinoma metastases with high-dose-rate image-guided interstitial brachytherapy: a single center experience
por: Drewes, Ralph, et al.
Publicado: (2019)

Peripheral blood-based cell signature indicates response to interstitial brachytherapy in primary liver cancer
por: Kästle, Sophia, et al.
Publicado: (2023)

Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases
por: Seidensticker, Max, et al.
Publicado: (2010)

Prospective Randomized Trial of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid for Prevention of Radiation-Induced Liver Toxicity
por: Seidensticker, Max, et al.
Publicado: (2014)

Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (HDR) brachytherapy of liver metastases
por: Damm, Robert, et al.
Publicado: (2022)

Early monocyte response following local ablation in hepatocellular carcinoma
por: Kimm, Melanie A., et al.
Publicado: (2022)

Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system
por: Damm, Robert, et al.
Publicado: (2016)

Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases
por: Rühl, Ricarda, et al.
Publicado: (2010)

Image-guided interstitial high-dose-rate brachytherapy in the treatment of metastatic esophageal squamous cell carcinoma
por: Omari, Jazan, et al.
Publicado: (2018)

Semi-Automatic MRI Feature Assessment in Small- and Medium-Volume Benign Prostatic Hyperplasia after Prostatic Artery Embolization
por: Schmidt, Vanessa F., et al.
Publicado: (2022)

Tumor-Associated Macrophages—Implications for Molecular Oncology and Imaging
por: Kimm, Melanie A., et al.
Publicado: (2021)

Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib
por: Öcal, Osman, et al.
Publicado: (2022)

Needle track seeding in hepatocellular carcinoma after local ablation by high-dose-rate brachytherapy: a retrospective study of 588 catheter placements
por: Damm, Robert, et al.
Publicado: (2018)

Post-therapeutic microRNA-146a in liquid biopsies may determine prognosis in metastatic gastrointestinal cancer patients receiving (90)Y-radioembolization
por: Hirner-Eppeneder, Heidrun, et al.
Publicado: (2023)

Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease Following Radioembolization
por: Seidensticker, Max, et al.
Publicado: (2021)

Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)
por: Seidensticker, Max, et al.
Publicado: (2015)

Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma
por: Öcal, Osman, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_28l7evubp2krgc86bq42lfrcof